Clinical Trial Update: Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating continuous lenalidomide therapy versus observation after induction without lenalidomide, pomalidomide or thalidomide in multiple myelom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma, Neoplasms | Phase 3 | Status: WITHDRAWN